February 28, 2023
UC San Diego’s new Astrobiotechnology Hub brings together leaders in academia, biotechnology and aerospace industries under a united mission to advance stem cell science and commercialization in space.
June 3, 2021
Developing improved materials for things such as energy storage and drug discovery is of interest to researchers and society alike. Quantum mechanics is the basis for molecular and materials scientists who develop these useful, futuristic products.
June 8, 2015
The Sanford Consortium for Regenerative Medicine in La Jolla, California, and the Takeda Pharmaceutical Company Limited (Takeda) have agreed to establish a $10-million, five-year Innovation Alliance that would advance each organization’s research missions.
April 4, 2019
An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies – and thus vulnerabilities – of pancreatic cancer stem cells.
March 5, 2012
A team of scientists at the University of California, San Diego Moores Cancer Center has identified a novel protein expressed by breast cancer cells – but not normal adult tissues – that could provide a new target for future anti-cancer drugs and treatments.
October 10, 2013
…the internationally renowned biologist—whose discoveries have shaped our understanding of how genes regulate early embryonic development—had been focused primarily on his research and teaching activities. But as the new dean, his belief in the importance of educating every undergraduate student about the principles of evolution, the need to make biology…
March 7, 2012
Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for improving memory deficits and reducing the pathology of Alzheimer’s disease (AD) in an…
January 20, 2021
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
October 10, 2011
A newly developed method for microscopically extracting, or “mining,” information from genomes could represent a significant boost in the search for new therapeutic drugs and improve science’s understanding of basic functions such as how cells communicate with one another.
March 27, 2013
…regulating the recovery of peripheral nerves after injury. The discovery has implications for improving the treatment of neuropathic pain, a complex and largely mysterious form of chronic pain that afflicts over 100 million Americans.
